With Becton Dickinson trading at US$145.31, many investors are asking a simple question: is the current price giving fair value for a global medical equipment leader, or has the market moved too far in one direction?

Recent returns, including a 6.6% decline over the last 7 days, 6.1% over 30 days, 25.5% year to date and 8.6% over the past year, suggest sentiment around the stock has shifted and may be influencing how the market is thinking about risk and opportunity.

While there has not been a single headline event behind these moves, the ongoing flow of sector and company updates has kept attention on how dependable Becton Dickinson’s business model and balance sheet are. For investors, that context matters because it shapes whether…